OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
67
Results
Show all
Save search
Copy query
Show results for
Unknown
(66)
Proteomics
(1)
Repository
MassIVE
(1)
Publication Date
2013
(1)
Release Date
2020
(9)
2025
(8)
2023
(8)
2024
(7)
2022
(7)
2016
(5)
2010
(5)
2021
(3)
2018
(3)
2026
(2)
2013
(2)
2012
(2)
2019
(1)
2015
(1)
2014
(1)
2011
(1)
2008
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
Zanubrutinib for treatment-naive and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study.
Not available
S-EPMC9300083
|
biostudies-literature
Cite
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study.
Not available
S-EPMC10589773
|
biostudies-literature
Cite
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2
EV
Study.
Not available
S-EPMC11557677
|
biostudies-literature
Cite
Zanubrutinib for the treatment of patients with Waldenstrom macroglobulinemia: 3 years of follow-up.
Not available
S-EPMC7596846
|
biostudies-literature
Cite
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.
Not available
S-EPMC12824668
|
biostudies-literature
Cite
Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry.
Not available
S-EPMC6430142
|
biostudies-literature
Cite
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.
Not available
S-EPMC4874148
|
biostudies-literature
Cite
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.
Not available
S-EPMC2905628
|
biostudies-literature
Cite
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Not available
S-EPMC3515768
|
biostudies-literature
Cite
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Not available
S-EPMC4026579
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets